Kolmar Korea : Interim Report on Business Performance (Fair Disclosure)
August 17, 2022 at 03:24 am EDT
Share
Interim Report on Business Performance (Fair Disclosure)
※ The following are interim figures, and may be different from final data.
1. Details of business performance
in KRW 100 mn, %
Category
Current period
Previous period
Changes over previous period (%)
Same period of last year
Changes over same period of last year (%)
(22.2Q)
(22.1Q)
(21.2Q)
Sales
Current
2,058
1,794
14.72
1,702
20.92
Cumulative
3,852
1,794
-
3,426
12.43
Operating income
Current
229
144
59.03
199
15.08
Cumulative
373
144
-
357
4.48
Net income from continuing operation before income tax
Current
255
163
56.44
184
38.59
Cumulative
418
163
-
352
18.75
Net income
Current
116
124
-6.45
140
-17.14
Cumulative
240
124
-
267
-10.11
-
-
-
-
-
-
2. Details of information released
Information provider
IR Team, Kolmar Korea
Information recipients
Domestic and foreign investors, media organizations, etc.
Date & time of information released
To be disclosed as needed after fair disclosure
Title and place of event held
-
3. Contact points (department/phone number)
IR Team, Kolmar Korea (02-515-0150)
4. Other matters to be factored into investment decisions
- The earnings results above are based on the separate financial statements prepared in accordance with Korean International Financial Reporting Standards (K-IFRS).
- The results above have not been audited by an external auditor, and thus are subject to change in the course of the external audit.
※ Related disclosure
-
Attachments
Original Link
Original Document
Permalink
Disclaimer
Kolmar Korea Holdings Co. Ltd. published this content on 17 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 August 2022 07:23:05 UTC.
Kolmar Holdings Co Ltd, formerly KOLMAR KOREA HOLDINGS CO., LTD., is a Korea-based holding company engaged in the manufacture and sale of food. The Company is engaged in the original development and design manufacturing (ODM) of cosmetics, original equipment manufacturing (OEM) of pharmaceuticals, leasing of real estates and others. In addition, the Company is engaged in the manufacture and sale of health foods and other products.